Biocept, Inc. filed a voluntary petition liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware on October 13, 2023. The debtor listed its assets of $2.49 million and liabilities of $2.92 million. The debtor is represented by Matthew P. Ward of Womble Bond Dickinson (US) LLP as its legal counsel.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% |
|
0.00% | -99.76% |
Apr. 26 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
Apr. 02 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-99.76% | 262 | |
-4.72% | 12.35B | |
+99.06% | 8.55B | |
-22.10% | 6.6B | |
+8.48% | 5.88B | |
-22.96% | 3.52B | |
+6.08% | 2.55B | |
+38.04% | 2.39B | |
-7.04% | 2.33B | |
-68.75% | 2.09B |
- Stock Market
- Equities
- BIOCQ Stock
- News Biocept, Inc.
- Biocept, Inc. Filed for Bankruptcy